Clinical trial
Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With…
NCT00080405 · Millennium Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00080405 |
|---|---|
| Title | Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple Myeloma |
| Official title | Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple Myeloma |
| Lead sponsor | Millennium Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Bortezomib |
| Enrollment | 40 |
| Start date | Mar 1, 2004 |
| Primary completion | Jun 1, 2005 |
| First posted | Apr 2, 2004 |
| Last update posted | Mar 27, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: